Login / Signup
Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?
Tülay Kuş
Gokmen Aktas
Irfan Cicin
Published in:
The oncologist (2023)
Keyphrases
</>
phase ii
clinical trial
open label
double blind
phase iii